Comparing Depression Relapse in Older Patients
Author Information
Author(s): Lyketsos Constantine G, Weiller Emmanuelle, Katona Cornelius, Gorwood Phillip
Primary Institution: Johns Hopkins University
Hypothesis
Old-old and young-old patients on escitalopram would have comparable benefits with regard to prevention of relapse and initial remission.
Conclusion
Both young-old and old-old patients with major depression had similar rates of remission after treatment with escitalopram, and both groups experienced significantly lower relapse rates compared to those on placebo.
Supporting Evidence
- 78% of young-old patients and 72% of old-old patients achieved remission after treatment.
- Escitalopram was well tolerated in both age groups.
- The hazard ratio for relapse on placebo versus escitalopram was 4.4.
Takeaway
This study looked at older people with depression and found that those who took escitalopram had a much lower chance of getting sad again compared to those who didn't take it.
Methodology
Patients aged 65 and older were treated with escitalopram for 12 weeks, then randomized to continue escitalopram or switch to placebo for 24 weeks, with efficacy assessed using the MADRS.
Potential Biases
The study's design may introduce bias due to the retrospective nature of the age group analysis.
Limitations
The analysis by age group was retrospective, and the inclusion and exclusion criteria limit the generalizability of findings.
Participant Demographics
Participants were outpatients aged 65 years and older, with 254 young-old (65-74 years) and 151 old-old (≥75 years) patients.
Statistical Information
P-Value
p < 0.001
Confidence Interval
95% CI: 2.4 to 8.1
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website